title: The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions.
abstract: Despite intense effort, obesity is still rising throughout the world. Links between obesity and cardiovascular diseases are now well established. Most of the cardiovascular changes related to obesity can be followed by magnetic resonance imaging (MRI) or by magnetic resonance spectroscopy (MRS). In particular, we will see in this review that MRI/MRS is extremely well suited to depict (1) changes in cardiac mass and function, (2) changes in stroke volume, (3) accumulation of fat inside the mediastinum or even inside the cardiomyocytes, (4) cell viability and (5) molecular changes during early cardiovascular diseases.
authors.affiliation: Department of Radiology, Geneva University Hospital, Geneva, Switzerland.
authors.forename: K
authors.initials: K
authors.lastname: Montet-Abou
authors.forename: M
authors.initials: M
authors.lastname: Viallon
authors.forename: J-N
authors.initials: JN
authors.lastname: Hyacinthe
authors.forename: B
authors.initials: B
authors.lastname: Delattre
authors.forename: J-P
authors.initials: JP
authors.lastname: Vallee
authors.forename: D
authors.initials: D
authors.lastname: Didier
authors.forename: P
authors.initials: P
authors.lastname: Croisille
authors.forename: X
authors.initials: X
authors.lastname: Montet
mesh_terms: D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000503:physiopathology; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D009765:Obesity / Q000150:complications* / Q000503:physiopathology